Citation: | LI Qiang, WANG Wendie, JIA Yue, ZHENG Yuzhao, ZHOU Jianping, YIN Tingjie. Effect of solubilizing strategies on oral absorption of felodipine[J]. Journal of China Pharmaceutical University, 2021, 52(2): 195-202. DOI: 10.11665/j.issn.1000-5048.20210208 |
[1] |
. Drug Eval Res(药物评价研究),2019,42(5):1014-1019.
|
[2] |
Lüscher TF,Cosentino F. The classification of calcium antagonists and their selection in the treatment of hypertension. areappraisal[J]. Drugs,1998,55(4):509-517.
|
[3] |
Zhou Z,Dunn C,Khadra I,et al. Influence of physiological gastrointestinal surfactant ratio on the equilibrium solubility of BCS Class II drugs investigated using a four component mixture design[J]. Mol Pharm,2017,14(12):4132-4144.
|
[4] |
?těpánková M,Krasulová K,Do?i?áková A,et al. Optical isomers of dihydropyridine calcium channel blockers display enantiospecific effects on the expression and enzyme activities of human xenobiotics-metabolizing cytochromes P450[J]. Toxicol Lett,2016,262:173-186.
|
[5] |
Jing BY,Wang ZY,Yang R,et al. Enhanced oral bioavailability of felodipine by novel solid self-microemulsifying tablets[J]. Drug Dev Ind Pharm,2016,42(3):506-512.
|
[6] |
Zhang CG,Yu ZY,Yu CC,et al. Research progress of gastroretentive drug delivery system and its application in traditional Chinese medicine[J]. Chin J Mod Appl Pharm(中国现代应用药学),2020,37(7):877-885.
|
[7] |
Jing BY,Wang ZY,Li Y,et al. Preparation and in vitro evaluation of felodipinesolid dispersions[J]. J Shenyang Pharm Univ(沈阳药科大学学报),2010,27(3):185-190.
|
[8] |
Mori D,Makwana J,Parmar R,et al. Formulation, evaluation and optimization of the felodipine nanosuspension to be used for direct compression to tablet for in vitro dissolution enhancement[J]. Pak J Pharm Sci,2016,29(6):1927-1936.
|
[9] |
Yang H,Zhai B,Fan Y,et al. Intestinal absorption mechanisms of araloside a in situ single-pass intestinal perfusion and in vitro caco-2 cell model[J]. Biomed Pharmacother. 2018,106:1563-1569.
|
[10] |
Zawaneh AH,Khalil NN,Ibrahim SA,et al. Micelle-enhanced direct spectrofluorimetric method for the determination of linifanib: application to stability studies[J]. Luminescence,2017,32(7):1162-1168.
|
[11] |
He CH,Zhang ZH,Wang S,et al. Study on intestinal absorption kinetics of apigenin in rats[J]. Chin J Chin Mater Med(中国中药杂志),2013,38(9):1416-1420.
|
[12] |
Luo YF,Ren LX,Li XH,et al. Summary of research methods for drug intestinal absorption[J]. Drug Eval Res(药物评价研究),2017,40(5):706-710.
|
[13] |
Zhou YJ,Qin DP,Wang YD,et al. Amelioration of tripterygium wilfordii polycoride on TNBS/ethanolinduced ulcerative colitis via inhibiting lipid peroxidation and its downstream inflammatory meditors[J]. Chin Herb Med(中草药 英文版),2017,9(4):344-352.
|
[14] |
Over B,Matsson P,Tyrchan C,et al. Structural and conformational determinants of macrocycle cell permeability[J]. Nat Chem Biol,2016,12(12):1065-1074.
|
[1] | ZHAO Xiujuan, YANG Hengli, WU Jinye, ZHENG Xiaoqi, ZHANG Yaoping, LIN Yuping, HU Chunyan. Synthesis and anti-inflammatory activity of three series of coumarin-based derivatives[J]. Journal of China Pharmaceutical University, 2025, 56(1): 40-48. DOI: 10.11665/j.issn.1000-5048.2024072101 |
[2] | ZHU Hong, WEI Xiaopeng, JIN Meihua, QIN Nan. Synthesis and inhibition of NO production activities of 1, 6-O, O-diacylbritannilactone derivatives[J]. Journal of China Pharmaceutical University, 2017, 48(4): 440-444. DOI: 10.11665/j.issn.1000-5048.20170408 |
[3] | MOU Yi, CHEN Tong, HUANG Zhangjian, LAI Yisheng, PENG Sixun, JI Hui, ZHANG Yihua. Design, synthesis and anti-inflammatory evaluation of CDDO-Me ester prodrugs[J]. Journal of China Pharmaceutical University, 2016, 47(6): 661-665. DOI: 10.11665/j.issn.1000-5048.20160605 |
[4] | XU Guijun, LI Zhijun, WANG Qi, TAN Jiejun, SHI Guoshan, QI Wei, LI Di, WANG Youpeng. Isolation and identification of anti-inflammatory constituents from Houttuynia cordata[J]. Journal of China Pharmaceutical University, 2016, 47(3): 294-298. DOI: 10.11665/j.issn.1000-5048.20160308 |
[5] | WU Mingming, FANG Lei, GOU Shaohua, CHEN Li. 以2-甲基-2-取代苯氧基丙酸为离去基团的铂(Ⅱ)配合物的合成、表征及细胞毒活性[J]. Journal of China Pharmaceutical University, 2013, 44(4): 303-306. DOI: 10.11665/j.issn.1000-5048.20130403 |
[6] | HUANG Wen-xing, LAI Yi-sheng, ZHANG Yi-hua, WANG Zhen-guo, ZHANG Zhi-hao, MA Lin, JI Hui. Synthesis and anti-inflammatory activity of p-(sulfamyl)benzylidene-linked heterocyclic ketone derivatives[J]. Journal of China Pharmaceutical University, 2009, 40(6): 497-502. |
[7] | AO Gui-zhen, ZHENG Li-ling, XU Guang-lin, LI Jing. Synthesis and anti-inflammatory activity of α-aryl-3,5-dimethoxyphenylpropenamides[J]. Journal of China Pharmaceutical University, 2009, 40(4): 302-305. |
[8] | Synthesis and anti-inflammatory activities of aryl alkyl acid NSAIDs tetraacetylated glucoside derivatives[J]. Journal of China Pharmaceutical University, 2009, 40(1): 26-30. |
[9] | Synthesis and anti-inflammatory activities of imidazo[1,2-a] pyrimidine derivatives[J]. Journal of China Pharmaceutical University, 2009, 40(1): 16-20. |
[10] | Synthesis and Anti-inflammatory Activity of Nitric Oxidedonating α-Substituted p-(Methanesulfonyl)phenylpropenoic Acid Esters[J]. Journal of China Pharmaceutical University, 2004, (3): 6-10. |